KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Common Equity (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Common Equity for 7 consecutive years, with $340.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity changed 0.36% year-over-year to $340.9 million, compared with a TTM value of $340.9 million through Sep 2025, changed 0.36%, and an annual FY2024 reading of $341.1 million, up 19.12% over the prior year.
  • Common Equity was $340.9 million for Q3 2025 at Clover Health Investments, down from $344.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $588.9 million in Q1 2021 and bottomed at $286.4 million in Q4 2023.
  • Average Common Equity over 5 years is $374.0 million, with a median of $341.1 million recorded in 2024.
  • The sharpest move saw Common Equity surged 215.72% in 2021, then crashed 34.11% in 2023.
  • Year by year, Common Equity stood at $540.0 million in 2021, then tumbled by 33.91% to $356.9 million in 2022, then decreased by 19.75% to $286.4 million in 2023, then grew by 19.12% to $341.1 million in 2024, then dropped by 0.06% to $340.9 million in 2025.
  • Business Quant data shows Common Equity for CLOV at $340.9 million in Q3 2025, $344.2 million in Q2 2025, and $336.1 million in Q1 2025.